JPS60146884A - Production of 1,5-benzothiazepine derivative - Google Patents

Production of 1,5-benzothiazepine derivative

Info

Publication number
JPS60146884A
JPS60146884A JP170284A JP170284A JPS60146884A JP S60146884 A JPS60146884 A JP S60146884A JP 170284 A JP170284 A JP 170284A JP 170284 A JP170284 A JP 170284A JP S60146884 A JPS60146884 A JP S60146884A
Authority
JP
Japan
Prior art keywords
formula
type
threo
propionic acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP170284A
Other languages
Japanese (ja)
Inventor
Yoshio Matsumura
松村 由夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemical Industrial Co Ltd
Original Assignee
Nippon Chemical Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemical Industrial Co Ltd filed Critical Nippon Chemical Industrial Co Ltd
Priority to JP170284A priority Critical patent/JPS60146884A/en
Publication of JPS60146884A publication Critical patent/JPS60146884A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

PURPOSE:To obtain the titled compound useful as pharmaceuticals, by condensing a specific thiophenol derivative with a propionic acid derivative, reacting with acetic anhydride after hydrolysis, and cyclizing the resultant threo-type propionic acid derivative with DCC. CONSTITUTION:The objective compound of formula V, i.e. cis-2-(4'-methoxy- phenyl )-3-acetoxy-5-( N,N-dimethylaminoethyl )-2, 3-dihydro-1, 5-benzothiazepin-4- 5(H)one, is produced by (1) condensing the 2-(N,N-dimethylaminoethyl)aminothiophenol alkali metal salt of formula I (M is Na or K) with the erythro-type 3-(4- methoxy-phenyl)-3-chloro-2-hydroxypropionic acid methyl ester of formula II, (2) hydrolyzing the resultant threo-type propionic acid derivative with an alkali, (3) reacting with acetic anhydride in the presence of a base to obtain the compound of formula IV, and (4) carrying out the intramolecular cyclization reaction of the threo-type propionic acid derivative of formula IV with DCC (N,N'-dicyclohexylcarbodiimide).

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は下記式(■)で示されるシス型1,5ベンゾチ
アゼピン誘導体、具体的にはシス−2−(4’−メトキ
シフエニ↑ル)−3−アセトキシ−5−(NNジメチル
アミノエチル)−2,3−ジヒドロ−1,5ベンゾチア
ゼピン−4−(5H)オン及びその塩類の製造法に関す
るものである。 C)Lt CH。 さらに詳しくは、式(V)で示される1、5ベンゾチア
ゼピン誘導体において、2位及び3位の炭素原子に結合
する水素原子の立体配位がシス型になる新規な製造法に
関する。 本発明によるシス型1,5ベンゾチアゼピン誘導体(V
lは冠血管拡張作用、向精神神経作用等含有する有用な
医薬化合物である。 本発明の式(V)の化合物は特公昭46−43785号
、特開昭57−136581号、特開昭58−1948
72号等に記載されている方法によって製造出来る。こ
れらの方法で製造する場合最後の工程において、水素化
ナトIIウム、及びNN−ジメチルアミノクロライド等
全反応試剤と使用するのであるが、水素化す) IIウ
ムは水によって爆発的に反応し、又空気中の湿気によっ
ても分解するなどその取扱いに注意全装する化合物であ
り、又NNジメチルアミンエチルクロライドは市販品の
NNジメチルアミノクロライド塩酸塩又はその水溶液を
脱塩酸して使用しなければならず、しかも反応に使用す
る溶媒等も充分乾燥したものを用いなければならない等
の不便がある。 本発明者は上記の製造上の不便を解決するため、新規な
製法を発明した。即ち下記式(1)で示される2−、(
N、Nジメチルアミンエチル)アミノチオフェノールを
出発原料とすることで解決した。 (式中Mはナトリウム、カリウムのアルカI)金属を表
わす) 式(+1の化合物は既知の方法(薬学雑誌77巻、34
7頁、及び88巻、1638頁)で製造できる。又式(
V)ノ化合物のシス型すブるには中間体物質の(111
1及び(給の化合物ばトレオ型の立体配位でなければな
らないHI CHり ■ NCCH−、h 本発明者は式(It)の化合物、即ち工11 )口型、
3−(4’−,7’)*ジフェニル)−3クロル−2−
ヒドロキシプロピオン酸メチルエステルを一方の出発原
料とすることにより解決した。式(11>の化合物に既
知の方法(J、C,S、Perkin n 1973巻
、653頁及び(:hemistry and Ind
ustry 1963巻、1985頁)で製造すること
ができた。 特開昭58−194872号の製造法には立体異性につ
いては記載がない。 以下本発明の製造法について詳細に説明する。 式(1)の化合物と式(II)の化合物の反応は、式(
りの化合物を含水メチルアルコール、エチルアルコール
、イソプロピルアルコール好ましくは含水エチルアルコ
ールに、式(+)の化合、物の1〜1.1当量の水酸化
ナト11ウム又は水酸化カリウム、好ましくは水酸化力
11ウムを溶解したアルコール浴液に式(1)の化合物
を加え溶解する。次いで式(If)の化合物の割合に当
量でよい。この反応で生じた式(In)の化合物は単離
しないで次の反応に進むことができる。 式(m)の化合物の加水分解は水酸化ナト11ウム又は
水酸化カリウムを含む含水アルコール中で行なわれ反応
時間は30分〜1時間11反応温度は20〜80℃が好
ましぐ特に45〜55℃が適している。 次いで化合物(酌は化合物(noの加水分解生成物であ
るトレオ型3−(4’メトキシフエ・ニル) −3−C
(2−NNジメチルアミノエチルアミン)フェニルチオ
〕−2−ヒドロオキシプロピオン酸を常法によりアセチ
ル化することによって得られる。即ち上記10ピオン酸
誘導体を塩基の存在下、無水酢酸を反応することにより
容易に化合物CF/) ’に得ることができる。こ\で
塩基としてはピ11ジン、三級アミン、アルカリ金属等
が用いられ、特にピリジンが適している。 使用する無水酢酸は1〜1,5当量又塩基は2当量以上
がよい。又ベンゼン、クロロホルム、NNジメチルホル
ムアミド等反応に影響のない溶媒を用いることが反応を
より円滑に進めること上で有利である。 反応製置は20〜50℃の範囲で進み反応時間は使用す
る塩基の種類((よって差があるも1〜3時間で反応は
終了する。 式(Vlの化合物は式(酌の化合物音ジオキサン全減圧
解L、N、N’ジシクロへキシルカルボジイミド(以下
単にり、CCと略記する)を加えることによって70 
゛チ以上の高収率で得られる。即ち、化合物(IV)の
ジオキサン溶液に1.1〜1.5当量のり、CC,を加
え、生ずるNNジシクロヘキシル尿素kF別してのぞき
ジオキサンを留去すれば目的物式(V)の化合物が得ら
れる。 こ、の化合物(V)は目的によって塩酸塩、臭化水系酸
塩等の塩にすることができる。 次に本発明を実施例により具体的に説明する。 実施例 (1)トレオ型、2−アセトオキシ−3−(4−メトキ
シフェニル)−3−[(2−NNジメチルアミノxf)
vアミン)フェニルチオ〕プロピオン酸〔化合物(m)
〕の合成 水酸化カリウム62全含む含水エチルアルコール50m
1VC2(NNジメチルアミノエチル)アミノチオフェ
ノールzywm解させ室温で攪拌しながら、2−ヒドロ
キシ−3−(4メトキシフエニ←ル)−3−クロル10
ピオン酸メチルエステル2.45fkエチルアルコール
5−に溶解して加え、1時間反応させた。ついで水酸化
力IIウム92全・水18tntに溶解したものを加え
50℃で30分攪拌した。反応後エチルアルコールを減
圧で留去し冷却してから水50f’を加え酢酸で中和し
クロロホルムで抽出
The present invention relates to cis-1,5-benzothiazepine derivatives represented by the following formula (■), specifically cis-2-(4'-methoxyphenyl)-3-acetoxy-5-(NN dimethylaminoethyl) The present invention relates to a method for producing -2,3-dihydro-1,5benzothiazepine-4-(5H)one and its salts. C) Lt CH. More specifically, the present invention relates to a novel production method in which the hydrogen atoms bonded to the 2- and 3-position carbon atoms have a cis configuration in the 1,5-benzothiazepine derivative represented by formula (V). Cis-1,5-benzothiazepine derivatives (V
1 is a useful pharmaceutical compound containing coronary vasodilator action, psychotropic action, etc. The compound of formula (V) of the present invention is disclosed in Japanese Patent Publication No. 46-43785, Japanese Patent Application Publication No. 57-136581, and Japanese Patent Application Publication No. 58-1948.
It can be manufactured by the method described in No. 72 etc. When produced by these methods, in the final step, all reaction reagents such as sodium hydride and NN-dimethylaminochloride are used, but hydride (II) reacts explosively with water, and It is a compound that must be handled with care as it decomposes when exposed to moisture in the air, and NN dimethylamine ethyl chloride must be used after dehydrochlorinating commercially available NN dimethylamino chloride hydrochloride or its aqueous solution. Moreover, there are inconveniences such as the fact that the solvent used in the reaction must be sufficiently dried. The present inventor invented a new manufacturing method to solve the above manufacturing inconvenience. That is, 2-, (
The problem was solved by using N,N dimethylamine ethyl) aminothiophenol as the starting material. (In the formula, M represents an alkali metal such as sodium or potassium))
7 pages, and 88 volumes, 1638 pages). Matata (
V) To subvert the cis form of the compound, the intermediate substance (111
1 and (the compound of the formula (It) must have a threo-type configuration) HI CH-,
3-(4'-,7')*diphenyl)-3chloro-2-
The problem was solved by using hydroxypropionic acid methyl ester as one of the starting materials. Compounds of formula (11) are prepared by known methods (J, C, S, Perkin n 1973, p. 653 and (: hemistry and ind.
ustry, Vol. 1963, p. 1985). The production method of JP-A-58-194872 does not mention stereoisomerism. The manufacturing method of the present invention will be explained in detail below. The reaction between the compound of formula (1) and the compound of formula (II) is expressed by the formula (
The compound of formula (+) is added to hydrous methyl alcohol, ethyl alcohol, isopropyl alcohol, preferably aqueous ethyl alcohol, and 1 to 1.1 equivalents of sodium hydroxide or potassium hydroxide, preferably hydroxide. The compound of formula (1) is added and dissolved in an alcohol bath solution in which 11 um of alcohol is dissolved. This may then be equivalent to the proportion of the compound of formula (If). The compound of formula (In) produced in this reaction can proceed to the next reaction without isolation. The hydrolysis of the compound of formula (m) is carried out in a hydrous alcohol containing 11 um of sodium hydroxide or potassium hydroxide, and the reaction time is 30 minutes to 1 hour. The reaction temperature is preferably 20 to 80°C, especially 45 to 1 hour. 55°C is suitable. Next, the compound (the cup is a threo-type 3-(4'methoxyphe-nyl)-3-C which is a hydrolysis product of the compound (no)
It is obtained by acetylating (2-NN dimethylaminoethylamine) phenylthio]-2-hydroxypropionic acid by a conventional method. That is, the compound CF/)' can be easily obtained by reacting the above 10 pionic acid derivatives with acetic anhydride in the presence of a base. Here, as the base, pyridine, tertiary amine, alkali metal, etc. are used, and pyridine is particularly suitable. The amount of acetic anhydride used is preferably 1 to 1.5 equivalents, and the amount of base used is preferably 2 equivalents or more. Furthermore, it is advantageous to use a solvent that does not affect the reaction, such as benzene, chloroform, or NN dimethylformamide, in order to make the reaction proceed more smoothly. The reaction process proceeds in the range of 20 to 50°C, and the reaction time varies depending on the type of base used, but the reaction is completed in 1 to 3 hours. By adding L, N, N' dicyclohexylcarbodiimide (hereinafter simply abbreviated as CC), 70
It can be obtained with a higher yield than 1. That is, by adding 1.1 to 1.5 equivalents of CC to a dioxane solution of compound (IV), separating the resulting NN dicyclohexyl urea kF, and distilling off the dioxane, the desired compound of formula (V) is obtained. Compound (V) can be converted into a salt such as a hydrochloride or an aqueous bromide salt depending on the purpose. Next, the present invention will be specifically explained using examples. Example (1) Threo type, 2-acetoxy-3-(4-methoxyphenyl)-3-[(2-NN dimethylamino xf)
v amine) phenylthio]propionic acid [compound (m)
] Synthesis of Potassium hydroxide 62% water-containing ethyl alcohol 50ml
1VC2 (NN dimethylaminoethyl) aminothiophenol zywm was dissolved and while stirring at room temperature, 2-hydroxy-3-(4methoxyphenyl)-3-chlor 10
Pionic acid methyl ester was dissolved in 2.45fk ethyl alcohol 5-, added and reacted for 1 hour. Then, a solution of 92% II hydroxide and 18tnt of water was added, and the mixture was stirred at 50°C for 30 minutes. After the reaction, ethyl alcohol was distilled off under reduced pressure, cooled, added 50 f' of water, neutralized with acetic acid, and extracted with chloroform.

【−水洗、乾燥後クロロホルム全減
圧で留去すると黄色の油状物3.52を得た。この油状
物をクロロホルム50m1に溶解しピ1】ジン5fを加
え30分室温で攪拌しついで無水酢酸1vをゆつくり加
え更に室温で1時間攪拌した。反応後クロロホルムを水
洗j−減圧でクロロホルムを留去し、水100m7!を
加え塩酸で中和し析出する結晶?F取乾燥し、エチルア
ルコールより再結してトレオ型化合物(M13.5りが
得られた。m、p、95〜98℃ 収率80チ:2) 
シス2−(4’−メトキシフェニル)−3−アセトキシ
−5−(NNジメチルアミンエチル)−2、3−ジヒド
ロ−1,5−ベンゾチアゼピン−4−(5H)★オン(
化合物(Vン)の合成 トレオ型化合物(ri’)4.3fiジオキサン50r
ntに溶解させ室温で5時間攪拌し一夜放置後、析出結
晶を濾過しジオキサン全減圧で留去して油状物4.2r
’に得た。これにジイソグロビルエーテルを加えて結晶
化させてm、p、133〜135℃の化合物(V)3.
3f’i得た。収率80チ 本物質ヲジエチルエーテルに溶解し塩化水素飽和ジエチ
ルエーテル溶液を加えると結晶が析出する。 p取乾燥すればm、p、185〜187℃のシス型化合
物(Vlの塩酸塩3vが得られた。
[-After washing with water and drying, chloroform was distilled off under total vacuum to obtain a yellow oily substance (3.52%). This oil was dissolved in 50 ml of chloroform, 5f of pyridine was added thereto, and the mixture was stirred at room temperature for 30 minutes, and then 1v of acetic anhydride was slowly added thereto, and the mixture was further stirred at room temperature for 1 hour. After the reaction, the chloroform was washed with water and the chloroform was distilled off under reduced pressure, leaving 100 m7 of water! Crystals that precipitate by adding and neutralizing with hydrochloric acid? It was dried and reconstituted from ethyl alcohol to obtain a threo-type compound (M13.5. m, p, 95-98°C, yield 80:2).
cis 2-(4'-methoxyphenyl)-3-acetoxy-5-(NNdimethylamineethyl)-2,3-dihydro-1,5-benzothiazepine-4-(5H)★one (
Synthesis of compound (Vn) Threo-type compound (ri') 4.3fi dioxane 50r
After stirring at room temperature for 5 hours and standing overnight, the precipitated crystals were filtered and dioxane was distilled off under reduced pressure to give an oily product of 4.2 liters.
'I got it. Diisoglobyl ether was added to this and crystallized to give compound (V) 3. m, p, 133-135°C.
I got 3f'i. Yield: 80% This substance was dissolved in diethyl ether and a hydrogen chloride saturated diethyl ether solution was added to precipitate crystals. When the mixture was removed and dried, a cis-type compound (Vl hydrochloride 3v) with m, p, and a temperature of 185 to 187°C was obtained.

Claims (1)

【特許請求の範囲】 下記式(r) (式中Mはケトリウム、カリウムのアルカ’l:Mを表
わす) で示される、2−(N、Nジメチルアミノエチル)アミ
ノチオフェノールアルカリ金属塩と下記式(n)で示さ
れる工1)トロ型、3−(4−メトキシ・フェニル)−
3−クロル−2−ヒドロキシプロピオン酸メチルエステ
ルを縮合させ、下記式(Ill)で示されるトレオ型、
3−(4’−メトキシフェニル)−3−((2−N、N
ジメチルアミノエチルアミノ)フェニルチオ〕−2−ヒ
ドロオキシ・プロピオン酸メチルエステルとし、この式
(II)で示されるトレオ型、グロビオン酸銹導体をア
ルカリ加水分解後塩基の存在下無水酢酸と反応させ下記
式(関 CM。 L N・(CH−)! で示されるトレオ型、2−アセトオキシ−3−(4’−
メトキシフエニル)−”3−[2−(N、Nジメチルア
ミノエチルアミノ)フェニルチオ〕−プロピオン酸とし
、この式(F/)で示される、トレオ型プロピオン酸誘
導体にN 、 N’ジシクロへキシルカルボジイミドを
用いて分子内閉環反応をさせることを特徴とする下記式
(V) CHり で示されるシス−2−(4’−メトキシフエニ苓ル)−
3−アセトキシ−5−(NNジメチルアミノエチル)−
2,3−ジヒドロ−1,5ベンゾチアゼピン−4−(5
H)オン及びその塩類の製造法。
[Claims] A 2-(N,N dimethylaminoethyl)aminothiophenol alkali metal salt represented by the following formula (r) (wherein M represents an alkali of ketorium or potassium) and the following: Formula (n) 1) Toro type, 3-(4-methoxy phenyl)-
By condensing 3-chloro-2-hydroxypropionic acid methyl ester, a threo type represented by the following formula (Ill),
3-(4'-methoxyphenyl)-3-((2-N,N
dimethylaminoethylamino)phenylthio]-2-hydroxy propionic acid methyl ester, and the threo-type globionic acid salt conductor represented by formula (II) was subjected to alkali hydrolysis and then reacted with acetic anhydride in the presence of a base to form the following formula ( Seki CM. Threo type, 2-acetoxy-3-(4'-
methoxyphenyl)-3-[2-(N,N dimethylaminoethylamino)phenylthio]-propionic acid, and the threo-type propionic acid derivative represented by the formula (F/) has N, N' dicyclohexyl Cis-2-(4'-methoxyphenyl)- represented by the following formula (V) CH, which is characterized by carrying out an intramolecular ring-closing reaction using carbodiimide.
3-acetoxy-5-(NNdimethylaminoethyl)-
2,3-dihydro-1,5benzothiazepine-4-(5
H) Process for producing on and its salts.
JP170284A 1984-01-09 1984-01-09 Production of 1,5-benzothiazepine derivative Pending JPS60146884A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP170284A JPS60146884A (en) 1984-01-09 1984-01-09 Production of 1,5-benzothiazepine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP170284A JPS60146884A (en) 1984-01-09 1984-01-09 Production of 1,5-benzothiazepine derivative

Publications (1)

Publication Number Publication Date
JPS60146884A true JPS60146884A (en) 1985-08-02

Family

ID=11508873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP170284A Pending JPS60146884A (en) 1984-01-09 1984-01-09 Production of 1,5-benzothiazepine derivative

Country Status (1)

Country Link
JP (1) JPS60146884A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623192A1 (en) * 1987-11-13 1989-05-19 Tanabe Seiyaku Co Process for preparing 1,5-benzothiazepine derivatives
JPH0623105B2 (en) * 1988-05-24 1994-03-30 マリオン ラボラトリーズ,インコーポレーテッド Pharmaceutical composition for the treatment of epileptic seizures
EP0609031A1 (en) * 1993-01-27 1994-08-03 Shionogi & Co., Ltd. Process for preparing benzothiazepine derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623192A1 (en) * 1987-11-13 1989-05-19 Tanabe Seiyaku Co Process for preparing 1,5-benzothiazepine derivatives
JPH01128974A (en) * 1987-11-13 1989-05-22 Tanabe Seiyaku Co Ltd Production of 1,5-benzothiazepin derivative
JPH0623105B2 (en) * 1988-05-24 1994-03-30 マリオン ラボラトリーズ,インコーポレーテッド Pharmaceutical composition for the treatment of epileptic seizures
EP0609031A1 (en) * 1993-01-27 1994-08-03 Shionogi & Co., Ltd. Process for preparing benzothiazepine derivatives
CN1040751C (en) * 1993-01-27 1998-11-18 盐野义制药株式会社 Process for preparation benzothiazepine derivatives

Similar Documents

Publication Publication Date Title
JPS63139182A (en) Production of thiazolidinedione derivative
HU196820B (en) Process for producing hydrated acid additional salts of 7-halogeno-7-deoxy-lincomycin
JP2556722B2 (en) Novel sulfonamide compound
US5034541A (en) Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z
JP3850838B2 (en) Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
JPS5922711B2 (en) Method for producing benzoxazolinone derivatives
EP0219256B1 (en) N-alkylation of dihydrolysergic acid
JPS60146884A (en) Production of 1,5-benzothiazepine derivative
KR100317147B1 (en) 3-(2-Amino-4-thiazolyl)-L-alanine and Process for Preparing the Same
EP0664799B1 (en) Amide derivatives
JPH082873B2 (en) Method for producing octahydroindole derivative
JPH0670064B2 (en) Bicyclic imidazole derivative
JPH04330070A (en) Preparation of labdane compound
JPS62155268A (en) Synthesis of nizatidine
SU900802A3 (en) Process for preparing ethyleleiminocyanoazomethines
US3442890A (en) Substituted 3-benzazocin-16-ones
JP3089373B2 (en) Method for producing 2-mercapto-phenothiazine
US6710185B2 (en) Process for the preparation of cell proliferation inhibitors
JPH0217169A (en) 2-hydroxy-3-(4-methoxyphenyl)-3-(2-aminophenylthio )propionic 8'-phenylmethyl ester and production thereof
HU194164B (en) Process for production of 1,2-dihydroxi-3-//2-indolil-1,1-dialkyl-ethil/-amin/-prophanes
BE858864A (en) NEW ESTERS OF PHENYL- AND PYRIDINE-3-CARBOXYLIC ACIDS AND PROCESS FOR THEIR PREPARATION
KR100241263B1 (en) Process for preparing n-alkyloxycarbonyl-beta-alkylsufonvaline
JP2005255630A (en) Ethyl trans-4-amino-1-cyclohexanecarboxylate salt and method for producing the same
JPH06340623A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JPH0377856A (en) Production of optically active atenolol and its intermediate